Soleno Therapeutics Stock Price on December 16, 2024

SLNO Stock  USD 44.31  0.87  1.93%   
Below is the normalized historical share price chart for Soleno Therapeutics extending back to November 13, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Soleno Therapeutics stands at 44.31, as last reported on the 23rd of December, with the highest price reaching 46.57 and the lowest price hitting 44.19 during the day.
IPO Date
13th of November 2014
200 Day MA
47.1344
50 Day MA
52.8974
Beta
(1.44)
 
Yuan Drop
 
Covid
If you're considering investing in Soleno Stock, it is important to understand the factors that can impact its price. Soleno Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0109, which indicates the firm had a -0.0109% return per unit of risk over the last 3 months. Soleno Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Soleno Therapeutics' Risk Adjusted Performance of (0.05), variance of 8.4, and Coefficient Of Variation of (1,503) to confirm the risk estimate we provide.
  
At this time, Soleno Therapeutics' Stock Based Compensation is very stable compared to the past year. . At this time, Soleno Therapeutics' Price Book Value Ratio is very stable compared to the past year. As of the 23rd of December 2024, Price Earnings To Growth Ratio is likely to grow to 7.21, though Price To Sales Ratio is likely to grow to (0.01). Soleno Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0109

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsSLNO

Estimated Market Risk

 2.77
  actual daily
24
76% of assets are more volatile

Expected Return

 -0.03
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.01
  actual daily
0
Most of other assets perform better
Based on monthly moving average Soleno Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Soleno Therapeutics by adding Soleno Therapeutics to a well-diversified portfolio.
Price Book
7.366
Book Value
6.45
Enterprise Value
1.7 B
Enterprise Value Ebitda
0.0233
Shares Float
27.5 M

Related Headline

Annexon Headline on 16th of December 2024

Real-World Evidence Study Strengthens the Body of Evidence Supporting ANX005 for Treatment of GBS ANX005 Phase 3 Population Was Matched 11 on...

Soleno Therapeutics Valuation on December 16, 2024

It is possible to determine the worth of Soleno Therapeutics on a given historical date. On December 16, 2024 Soleno was worth 46.99 at the beginning of the trading date compared to the closed value of 47.93. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Soleno Therapeutics stock. Still, in general, we apply an absolute valuation method to find Soleno Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Soleno Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Soleno Therapeutics' related companies.
 Open High Low Close Volume
  46.71    47.38    45.00    46.71    706,851  
12/16/2024
  46.99    48.77    46.82    47.93    684,246  
  47.40    48.03    47.24    47.65    591,760  
Backtest Soleno Therapeutics  |  Soleno Therapeutics History  |  Soleno Therapeutics Valuation   PreviousNext  
Open Value
46.99
47.93
Closing Value
55.31
Upside

Soleno Therapeutics Trading Date Momentum on December 16, 2024

On December 17 2024 Soleno Therapeutics was traded for  47.65  at the closing time. The top price for the day was 48.03  and the lowest listed price was  47.24 . The trading volume for the day was 591.8 K. The trading history from December 17, 2024 was a factor to the next trading day price decrease. The trading price change against the next closing price was 0.58% . The trading price change against the current closing price is 5.74% .

Soleno Therapeutics Fundamentals Correlations and Trends

By evaluating Soleno Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Soleno Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Soleno financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Soleno Therapeutics Stock history

Soleno Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Soleno is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Soleno Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Soleno Therapeutics stock prices may prove useful in developing a viable investing in Soleno Therapeutics
Last ReportedProjected for Next Year
Common Stock Shares Outstanding16.5 M17.3 M
Net Loss-21.7 M-22.7 M

Soleno Therapeutics Quarterly Net Working Capital

243.24 Million

Soleno Therapeutics Stock Technical Analysis

Soleno Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Soleno Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Soleno Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Soleno Therapeutics Period Price Range

Low
December 23, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Soleno Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Soleno Therapeutics December 23, 2024 Market Strength

Market strength indicators help investors to evaluate how Soleno Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Soleno Therapeutics shares will generate the highest return on investment. By undertsting and applying Soleno Therapeutics stock market strength indicators, traders can identify Soleno Therapeutics entry and exit signals to maximize returns

Soleno Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Soleno Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Soleno Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Soleno to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Soleno Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Soleno Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Soleno Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Soleno Therapeutics Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Soleno Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
To learn how to invest in Soleno Stock, please use our How to Invest in Soleno Therapeutics guide.
You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Soleno Therapeutics. If investors know Soleno will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Soleno Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.79)
Return On Assets
(0.48)
Return On Equity
(0.91)
The market value of Soleno Therapeutics is measured differently than its book value, which is the value of Soleno that is recorded on the company's balance sheet. Investors also form their own opinion of Soleno Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Soleno Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Soleno Therapeutics' market value can be influenced by many factors that don't directly affect Soleno Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Soleno Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Soleno Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Soleno Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.